Synthesis and preliminary cytotoxicity evaluation of water soluble pentacyclic triterpenoid phosphonates
- PMID: 39543237
- PMCID: PMC11564732
- DOI: 10.1038/s41598-024-76816-w
Synthesis and preliminary cytotoxicity evaluation of water soluble pentacyclic triterpenoid phosphonates
Abstract
Synthesis, solubility and cytotoxicity evaluation of anionic phosphonates derived from betulin, betulinic acid, oleanolic acid and ursolic acid is reported. Phosphonate moieties were successfully installed at terpenoid C28 by carboxylic acid deprotonation/alkylation sequence using (dimethoxyphosphoryl)methyl trifluoromethanesulfonate as alkylation reagent. Also, betulin-derived and ether-linked bis-phosphonate is obtained and characterized. After demethylation in the presence of TMSI the resulting phosphonic acids were transformed into their disodium salts. All target compounds display excellent water solubility, which was determined by qNMR in D2O. Cytotoxicity tests were performed in different concentrations of each compound (10-50 µM) against human osteosarcoma cell line MG-63 and osteoblast precursor cell line MC3T3-E1. Improved aqueous solubility and low cytotoxicity profile of the newly designed triterpenoid phosphonates reveal high potential for various medicinal chemistry and pharmacological applications in the future.
Keywords: Aqueous solubility; Cytotoxicity; Pentacyclic triterpenoids; Phosphonates.
© 2024. The Author(s).
Conflict of interest statement
Figures
References
-
- Newman, D. J. & Cragg, G. M. Natural products as sources of New drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod.83, 770–803. 10.1021/acs.jnatprod.9b01285 (2020). - PubMed
-
- Pezzuto, J. M. Plant-derived anticancer agents. Biochem. Pharmacol.53, 121–133. 10.1016/s0006-2952(96)00654-5 (1997). - PubMed
-
- Xiao, S. et al. Synthesis and anti-HCV entry activity studies of beta-cyclodextrin-pentacyclic triterpene conjugates. ChemMedChem. 9, 1060–1070. 10.1002/cmdc.201300545 (2014). - PubMed
MeSH terms
Substances
Grants and funding
- VPP-EM-BIOMEDICINA-2022/1-0001/Ministry of Economics Republic of Latvia
- VPP-EM-BIOMEDICINA-2022/1-0001/Ministry of Economics Republic of Latvia
- VPP-EM-BIOMEDICINA-2022/1-0001/Ministry of Economics Republic of Latvia
- VPP-EM-BIOMEDICINA-2022/1-0001/Ministry of Economics Republic of Latvia
- VPP-EM-BIOMEDICINA-2022/1-0001/Ministry of Economics Republic of Latvia
LinkOut - more resources
Full Text Sources
Miscellaneous
